Myriad Genetics Chief Executive Paul J. Diaz will leave the company April 30 to return to private equity firm Cressey & Co., where he will be a managing partner. The former Kindred Healthcare CEO ...

For more than 40 years, Cressey Development Group has been a fixture in the Lower Mainland property market. First under the direction of Norm Cressey and later guided by his son Scott, the company ...